Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 5/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21252801 | 0.82 | GPR3 (0.41) | ALOX5APFEN1GPR3PDE2ATRPA1 | |
| SCHEMBL23968984 | 0.73 | AR (0.32) | SCN9A | |
| SCHEMBL20083876 | 0.72 | GPR3 (0.32) | GPR3 | |
| SCHEMBL28364202 | 0.70 | TRPV4 (0.48) | GPR3FFAR4PDE2AACACBTRPA1 | |
| SCHEMBL23968968 | 0.70 | — | — | |
| SCHEMBL23968967 | 0.69 | — | — | |
| SCHEMBL23968863 | 0.68 | AR (0.40) | SCN9A | |
| SCHEMBL23969122 | 0.68 | KDM4E (0.39) | SCN9A | |
| SCHEMBL1263373 | 0.68 | GPR3 (0.42) | GPR3PDE2AACACBTRPA1SCN5A | |
| SCHEMBL23968948 | 0.67 | ALDH1A1 (0.37) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | ALOX5AP 3064/4885FEN1 2520/4885GPR3 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.